Leland Gershell

2016 - Tonix Pharmaceuticals Holding

In 2016, Leland Gershell earned a total compensation of $425.1K as Former Chief Financial Officer at Tonix Pharmaceuticals Holding, a 27% decrease compared to previous year.

Compensation breakdown

Salary$33,056
Other$392,000
Total$425,056

Gershell received $392K in other compensation, accounting for 92% of the total pay in 2016.

Gershell also received $33.1K in salary.

Rankings

In 2016, Leland Gershell's compensation ranked 11,717th out of 14,075 executives tracked by ExecPay. In other words, Gershell earned more than 16.8% of executives.

ClassificationRankingPercentile
All
11,717
out of 14,075
17th
Division
Manufacturing
4,577
out of 5,486
17th
Major group
Chemicals And Allied Products
1,637
out of 1,900
14th
Industry group
Drugs
1,326
out of 1,543
14th
Industry
Pharmaceutical Preparations
1,022
out of 1,173
13th
Source: SEC filing on May 2, 2017.

Gershell's colleagues

We found three more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2016.

2016

Seth Lederman

Tonix Pharmaceuticals Holding

Chief Executive Officer

2016

Gregory Sullivan

Tonix Pharmaceuticals Holding

Chief Medical Officer

2016

Bradley Saenger

Tonix Pharmaceuticals Holding

Chief Financial Officer

You may also like